MedPath

Timing of HCG Administration in IUI Cycles

Phase 4
Conditions
Infertility
Interventions
Registration Number
NCT02330705
Lead Sponsor
Mohamed Ibrahem Eid
Brief Summary

Evaluation of the effect of altering the timing of human chorionic gonadotropin (HCG) administration on the clinical pregnancy rate in intrauterine insemination (IUI) cycles.

Detailed Description

Women will be randomly divided into 3 groups; the first group will undergo IUI at the time HCG administration, the second group will undergo IUI 12 hours after HCG administration and the third group will undergo IUI 34-36 hours after HCG administration.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
225
Inclusion Criteria
  • Mild male factor infertility or unexplained infertility.
Exclusion Criteria
  • Advanced male factor infertility.
  • Polycystic ovary syndrome (PCOS) as defined by the Rotterdam criteria.
  • Endometriosis.
  • Tubal disease.
  • Uterine abnormalities or myoma.
  • Previous uterine surgery.
  • Metabolic or hormonal abnormalities.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group AHCGIUI at time of HCG
Group BHCGIUI 12 hours after HCG
Group CHCGIUI 34-36 hours after HCG
Primary Outcome Measures
NameTimeMethod
Clinical pregnancy rate4-6 weeks after IUI

Number of clinical pregnancies (defined as presence of at least one intrauterine gestational sac with fetal pole and cardiac activity on TVS scan at 4-6 weeks after IUI) divided by the number of IUI cycles

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Fertility care unit (FCU) in Mansoura University Hospitals

🇪🇬

Mansourah, Dakahlia, Egypt

Private fertility care centers

🇪🇬

Mansourah, Dakahlia, Egypt

© Copyright 2025. All Rights Reserved by MedPath